Topical treatment of dupilumab-associated refractory conjunctivitis and keratitis

PURPOSE: To report 3 cases of severe dupilumab-related conjunctivitis and keratitis topical treatment. OBSERVATION: Description, management, and outcomes of dupilumab-related refractory conjunctivitis associated with punctate keratitis. Three patients with atopic dermatitis (AD) experiencing severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Staso, Federico, Lambiase, Alessandro, Silvio Di Staso, Gattazzo, Irene, Ciancaglini, Marco, Scuderi, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807984/
https://www.ncbi.nlm.nih.gov/pubmed/35128157
http://dx.doi.org/10.1016/j.ajoc.2022.101309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807984/
https://www.ncbi.nlm.nih.gov/pubmed/35128157
http://dx.doi.org/10.1016/j.ajoc.2022.101309

Ejemplares similares